STAAR Surgical Co
Ouvert
SecteurSoins de santé
28.67 1.13
Résumé
Variation du prix de l'action
24h
Min
28.13
Max
28.7
Revenu | 5.2M 5.2M |
|---|---|
Ventes | 36M 94M |
BPA | 0.1 |
Marge bénéficiaire | 5.567 |
Employés | 921 |
EBITDA | 28M 20M |
Recommandations | Neutre |
|---|---|
Prévisions sur 12 Mois | +10.43% upside |
Prochains Résultats | 5 août 2026 |
|---|
Capitalisation Boursière | 106M 1.5B |
|---|---|
Ouverture précédente | 27.54 |
Clôture précédente | 28.67 |
Sentiment de l'Actualité
By Acuity
38%
62%
102 / 342 Classement par Healthcare
STAAR Surgical Co Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
À Propos STAAR Surgical Co
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.